DOI QR코드

DOI QR Code

Pseudomyogenic Hemangioendothelioma Involving the Esophagus: A Case Report

  • Received : 2020.12.14
  • Accepted : 2021.02.09
  • Published : 2021.12.05

Abstract

Herein, we describe the case of a 20-year-old woman who presented with dysphagia of 2 months' duration associated with vomiting, moderate abdominal pain, decreased oral intake, and significant weight loss. During the past 3 years, the patient experienced intermittent mild abdominal pain with infrequent vomiting. Endoscopy at Jordan University Hospital showed a mass in the esophagus, and endoscopic biopsies were performed. The preliminary histopathological report excluded malignancy. Two days after endoscopy, the patient presented to the emergency department complaining of severely worsening pain and total dysphagia. The pain persisted despite intravenous paracetamol administration, which was concerning for esophageal perforation; therefore, an urgent surgical intervention was performed. The mass was removed surgically, along with a para-esophageal lymph node. The final histopathological results of the endoscopic and resected specimens supported the diagnosis of pseudomyogenic hemangioendothelioma (PMHE). This is the first case reporting esophageal involvement of PMHE.

Keywords

References

  1. Hornick JL, Fletcher CD. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior. Am J Surg Pathol 2011;35:190-201. https://doi.org/10.1097/PAS.0b013e3181ff0901
  2. Fan C, Yang L, Lin X, Wang E. Pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma of the lower limb: report of a rare case. Diagn Pathol 2015;10:150. https://doi.org/10.1186/s13000-015-0384-z
  3. Al-Qaderi A, Mansour AT. Pseudomyogenic hemangioendothelioma. Arch Pathol Lab Med 2019;143:763-7. https://doi.org/10.5858/arpa.2017-0430-RS
  4. Sun Y, Zhao M, Lao IW, Yu L, Wang J. The clinicopathological spectrum of pseudomyogenic hemangioendothelioma: report of an additional series with review of the literature. Virchows Arch 2020;477:231-40. https://doi.org/10.1007/s00428-020-02753-4
  5. Agaram NP, Zhang L, Cotzia P, Antonescu CR. Expanding the spectrum of genetic alterations in pseudomyogenic hemangioendothelioma with recurrent novel ACTB-FOSB gene fusions. Am J Surg Pathol 2018;42:1653-61. https://doi.org/10.1097/PAS.0000000000001147
  6. Inyang A, Mertens F, Puls F, et al. Primary pseudomyogenic hemangioendothelioma of bone. Am J Surg Pathol 2016;40:587-98. https://doi.org/10.1097/PAS.0000000000000613
  7. Billings SD, Folpe AL, Weiss SW. Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol 2003;27:48-57. https://doi.org/10.1097/00000478-200301000-00006
  8. Pranteda G, Magri F, Muscianese M, et al. The management of pseudomyogenic hemangioendothelioma of the foot: a case report and review of the literature. Dermatol Ther 2018;31:e12725. https://doi.org/10.1111/dth.12725
  9. Horan NA, DiMaio DJ. Pseudomyogenic hemangioendothelioma. Cutis 2017;100:E13-6.